Unknown

Dataset Information

0

Molecular modeling, synthesis, characterization and pharmacological evaluation of benzo[d]oxazole derivatives as non-steroidal anti-inflammatory agents.


ABSTRACT: A series of N-(2-(4-chlorobenzyl)benzo[d]oxazol-5-yl)-3-substituted-propanamide (3a-3n) were synthesized and evaluated for their acute and chronic anti-inflammatory potential. The structure of the compounds was elucidated by elemental and spectral (IR, 1H NMR and MS) analysis. The synthesized compounds (at a dose of 20 mg/kg b.wt. p.o.) have shown their ability to provide 45.1-81.7% protection against carrageenan-induced paw edema, in comparison with diclofenac sodium (69.5%) and ibuprofen (64.7%). The most active compounds 3a, 3l and 3n were screened for chronic anti-inflammatory activity (cotton-pellet-induced granuloma) and to study their ulcerogenic activity. Compounds 3a, 3l and 3n showed 48.4%, 39.3% and 44.0% protection against cotton pellets-induced granuloma compared to diclofenac sodium (60.2%). The tested compounds were less ulcerogenic than the ibuprofen. Molecular modeling studies suggest that these compounds have strong interaction with the COX-2 enzyme, which is responsible for the activity.

SUBMITTER: Shakya AK 

PROVIDER: S-EPMC5094471 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular modeling, synthesis, characterization and pharmacological evaluation of benzo[d]oxazole derivatives as non-steroidal anti-inflammatory agents.

Shakya Ashok K AK   Kaur Avneet A   Al-Najjar Belal O BO   Naik Rajashri R RR  

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 20150325 5


A series of N-(2-(4-chlorobenzyl)benzo[d]oxazol-5-yl)-3-substituted-propanamide (<b>3a-3n</b>) were synthesized and evaluated for their acute and chronic anti-inflammatory potential. The structure of the compounds was elucidated by elemental and spectral (IR, <sup>1</sup>H NMR and MS) analysis. The synthesized compounds (at a dose of 20 mg/kg b.wt. p.o.) have shown their ability to provide 45.1-81.7% protection against carrageenan-induced paw edema, in comparison with diclofenac sodium (69.5%) a  ...[more]

Similar Datasets

| S-EPMC5343109 | biostudies-literature
| S-EPMC8271725 | biostudies-literature
| S-EPMC6540076 | biostudies-literature
| S-EPMC8434889 | biostudies-literature
| S-EPMC7499346 | biostudies-literature
| S-EPMC7153010 | biostudies-literature
| S-EPMC5081519 | biostudies-literature
| S-EPMC7397269 | biostudies-literature
| S-EPMC6269910 | biostudies-literature
2009-03-21 | GSE7584 | GEO